POLD1 and neoplasm: Specific POLD1 mutations, such as somatic p.S478N and germline p.L474P, impair Pol δ proofreading, leading to ultramutated tumors with tumor mutation frequent loads exceeding 100 variants/Mb and characteristic SBS10d signatures (54, 55).